Latest pharmaceutical industry Stories
DUBAI, UAE, May 26, 2015 /PRNewswire/ -- For the Last Decade Astellas Has Been Enhancing Patient Care & Quality of Life Throughout
LONDON, May 25, 2015 /PRNewswire/ -- Extra value: One year of free online updates included with this productThere are today at least 995 protein kinase inhibitor drugs known to affect
Once-daily oral medication to be reimbursed for first-line use MISSISSAUGA, ON, May 25, 2015 /CNW/ - Genzyme, a Sanofi company, announced today that PEI Pharmacare has included
RnRMarketResearch.com adds "Arrhythmias - Pipeline Review, H1 2015" to its store.
THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has commenced termination of its participation in the co-development and commercialization
OTTAWA, May 22, 2015 /CNW/ - More than fifty years ago, Thalidomide was approved by Health Canada and prescribed to treat morning sickness in expectant mothers.
CHAPEL HILL, N.C., May 22, 2015 /PRNewswire/ -- Effective staffing of key marketing services functions is critical to pharmaceutical brand recognition and success. Research and consulting leader
Statistically Significant Findings Identify Key Efficacy Targets for Phase IIb/III Clinical Trial with RGN-259 ROCKVILLE, Md., May 22, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals,
DUBLIN, May 22, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/3rthk2/latest)
- Unanimous Recommendation to Grant European Marketing Authorization for Omidria Based on Benefit/Risk Profile - SEATTLE, May 22, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER),
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).